Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
- 1 September 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 74 (3), 583-587
- https://doi.org/10.1161/01.cir.74.3.583
Abstract
The effect of pretreatment with heparin on lysis of arterial thrombi by tissue-type plasminogen activator (rt-PA) was studied in 19 dogs. Copper coil-induced carotid artery thrombi were weighed, inserted into the femoral arteries, and exposed to a 15 min infusion of rt-PA at 10 micrograms/kg/min either with (n = 6 thrombi) or without pretreatment with a 200 unit/kg bolus of heparin (n = 6 thrombi). The infusion of rt-PA without pretreatment reduced the thrombus weight by 27.6 +/- 7.4%, while infusion of rt-PA with pretreatment reduced it by 79.1 +/- 12.3% (p less than .0001). To test the hypothesis that heparin enhanced thrombolysis by preventing continued incorporation of new fibrin into the thrombus during thrombolysis we repeated the experiments using pretreatment with 8 U/kg of ancrod, which rapidly depletes fibrinogen. Pretreatment with ancrod (n = 6 thrombi) depleted fibrinogen and enhanced the lytic effect of rt-PA to a similar degree as pretreatment with heparin, resulting in a 67.6 +/- 12.3% (NS) decrease in thrombus weight. We conclude that heparin significantly enhances the thrombolytic effect of rt-PA, probably by preventing new fibrin formation and its incorporation into the thrombus during lysis.This publication has 14 references indexed in Scilit:
- Relation of effectiveness of intracoronary thrombolysis in acute myocardial infarction to systemic thrombolytic stateThe American Journal of Cardiology, 1985
- Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PAThrombosis and Haemostasis, 1985
- Systemic markers of fibrinolysis after unsuccessful intracoronary streptokinase thrombolysis for acute myocardial infarctionThe American Journal of Cardiology, 1984
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- Plasmin-antiplasmin complex formation during defibrase infusion in manThrombosis Research, 1977
- Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosisBlood, 1977
- RELATIONSHIP BETWEEN ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN IN EXPERIMENTAL VENOUS THROMBOSIS1977
- Treatment of Thrombosis by Sequential Therapy with Ancrod Followed by Streptokinase Clinical Pharmacology and RheologyPathophysiology of Haemostasis and Thrombosis, 1976
- Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolismBlood, 1975
- INTERACTION OF HEPARIN WITH FIBRINOLYSIS1963